Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Vertex Pharmaceuticals Incorporated    VRTX

Delayed Quote. Delayed  - 07/22 10:00:00 pm
93.89 USD   +0.73%
07/22 VERTEX PHARMACE : Moderna discuss mRNA Therapeutics in cystic fibros..
07/14 VERTEX PHARMACE : to Announce Second Quarter 2016 Financial Results ..
07/06 VERTEX PHARMACE : and Moderna to develop cystic fibrosis mRNA Therap..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
Latest news on VERTEX PHARMACEUTICALS INC
07/22 VERTEX PHARMACEUTICALS : Moderna discuss mRNA Therapeutics in cystic fibrosis
07/21 VERTEX PHARMACEUTICALS : to Announce Second Quarter 2016 Financial Results on Ju..
07/14 VERTEX PHARMACEUTICALS : Researchers at Vertex Pharmaceuticals Target Influenza ..
07/14 VERTEX PHARMACEUTICALS : to Announce Second Quarter 2016 Financial Results on Ju..
07/06 VERTEX PHARMACEUTICALS : and Moderna to develop cystic fibrosis mRNA Therapeutic..
07/06 VERTEX PHARMACEUTICALS : and Moderna Establish Exclusive Collaboration to Discov..
07/01 VERTEX PHARMACEUTICALS : Exploring the need for mutation-specific treatments in ..
06/23 VERTEX PHARMACEUTICALS : Reports from Vertex Pharmaceuticals Describe Recent Adv..
06/18 VERTEX PHARMACEUTICALS INCORPORATED : (VRTX) Stock Rating Reaffirmed by Jefferie..
06/17 VERTEX PHARMACEUTICALS : Orkambi’s cost too high for benefit offered, says..
06/16 VERTEX PHARMACEUTICALS : New Findings from Vertex Pharmaceuticals Inc. in the Ar..
06/15 VERTEX PHARMACEUTICALS INC / MA : Change in Directors or Principal Officers (for..
06/10 VERTEX PHARMACEUTICALS : Announces Presentations of Data for KALYDECO® (ivacafto..
06/09 VERTEX PHARMACEUTICALS : to Present at the Goldman Sachs Healthcare Conference o..
06/09 VERTEX PHARMACEUTICALS : U.S. FDA Accepts for Priority Review Supplemental New D..
06/02 VERTEX PHARMACEUTICALS : Spero Therapeutics Acquires Novel Gyrase Inhibitors fro..
06/02 VERTEX PHARMACEUTICALS : Study Results from Vertex Pharmaceuticals Provide New I..
05/31 VERTEX PHARMACEUTICALS : to Present at the Goldman Sachs Healthcare Conference o..
05/31 VERTEX PHARMACEUTICALS : U.S. FDA Accepts for Priority Review Supplemental New D..
04/28 VERTEX PHARMACEUTICALS : to Announce First Quarter 2016 Financial Results on Apr..
04/28 VERTEX PHARMACEUTICALS : Patent Issued for Solid Forms of 3-(6-(1-(2,2-Difluorob..
04/27 VERTEX PHARMACEUTICALS : reports 1Q loss
04/27 VERTEX PHARMACEUTICALS : Reports First Quarter 2016 Financial Results
04/21 VERTEX PHARMACEUTICALS : New Fenamates Study Findings Have Been Reported from Ve..
04/19 VERTEX PHARMACEUTICALS : Enterome signs IBD therapy agreement with Vertex
04/18 S&P 500 MOVERS : Chk, has
04/18 VERTEX PHARMACEUTICALS : Nivalis Therapeutics Appoints David Rodman, MD as Chief..
04/15 NASDAQ 100 MOVERS : Vrtx, nvda
04/15 VERTEX PHARMACEUTICALS : to Announce First Quarter 2016 Financial Results on Apr..
04/07 VERTEX PHARMACEUTICALS : Patent Issued for Methods of Regioselective Synthesis o..
04/07 BED BATH & BEYOND : Nasdaq 100 Movers: EBAY, BBBY
04/06 Mutual of America Capital Management LLC Acquires 173 Shares of Vertex Pharma..
04/06 NASDAQ 100 MOVERS : Wdc, vrtx
04/06DJHealth-Care Companies Lead U.S. Stocks Higher
04/05 VERTEX PHARMACEUTICALS : India Denies Vertex Patent on Cystic Fibrosis Drug Orka..
03/23 VERTEX PHARMACEUTICALS : Nasdaq 100 Movers: VRTX, NVDA
03/17 VERTEX PHARMACEUTICALS : to Present at the Barclays Healthcare Conference on Mar..
03/10 VERTEX PHARMACEUTICALS : to Present at the Barclays Healthcare Conference on Mar..
03/08 VERTEX PHARMACEUTICALS : Receives Australian Approval for ORKAMBI® (lumacaftor/i..
03/03 VERTEX PHARMACEUTICALS : Awards $1 Million in Grants to 18 Non-profit Organizati..
02/24 VERTEX PHARMACEUTICALS : Awards $1 Million in Grants to 18 Non-profit Organizati..
02/18 VERTEX PHARMACEUTICALS : Receives Complete Response Letter from U.S. FDA for Use..
02/18 VERTEX PHARMACEUTICALS : to Present at Upcoming Investor Conferences
02/16 VERTEX PHARMACEUTICALS : What Vertex’s Results Mean for Corbus, ProQR, and..
02/16 VERTEX PHARMACEUTICALS INCORPORATED : What Vertex’s Results Mean for Corbus, Pro..
02/11 VERTEX PHARMACEUTICALS : Patent Issued for Automated Developer for Immuno-Staine..
02/11 VERTEX PHARMACEUTICALS : Report Summarizes Rifampin Therapy Study Findings from ..
02/09 VERTEX PHARMACEUTICALS : to Present at Upcoming Investor Conferences
02/08 VERTEX PHARMACEUTICALS : FDA declines to approve Vertex's Kalydeco in people wit..
02/05 VERTEX PHARMACEUTICALS : Receives Complete Response Letter from U.S. FDA for Use..
02/04 VERTEX PHARMACEUTICALS : Health Canada Approves PrORKAMBI® lumacaftor/ivacaftor ..
02/04 VERTEX PHARMACEUTICALS : Findings from Vertex Pharmaceuticals Inc. Reveals New F..
01/28DJU.S. HOT STOCKS : Hot Stocks to Watch
01/27 VERTEX PHARMACEUTICALS : 4Q tops expectations on strong Orkambi sales
01/27 VERTEX PHARMACEUTICALS : Reports Full-Year and Fourth Quarter 2015 Financial Res..
01/26 VERTEX PHARMACEUTICALS : Health Canada Approves PrORKAMBI® (lumacaftor/ivacaftor..
01/14 VERTEX PHARMACEUTICALS : Announces Upcoming Presentation at the J.P. Morgan Heal..
01/11 NASDAQ 100 MOVERS : Lbtya, adi
01/10 VERTEX PHARMACEUTICALS : Outlines 2016 Business Priorities to Support the Discov..
01/07 VERTEX PHARMACEUTICALS : Mass Innovation Labs Spurs Partnerships between Members..
01/05 VERTEX PHARMACEUTICALS : Announces Upcoming Presentation at the J.P. Morgan Heal..
2015 VERTEX PHARMACEUTICALS : New Intercellular Signaling Peptides and Proteins Study..
2015 VERTEX PHARMACEUTICALS : Assigned Patent
2015 VERTEX PHARMACEUTICALS : Expert not convinced by new drug
2015 VERTEX PHARMACEUTICALS : Patent Issued for Dosage Units of 3-(6-(1-(2,2-Difluoro..
2015 VERTEX PHARMACEUTICALS : Appoints Michael J. Parini as Executive Vice President ..
2015 VERTEX PHARMACEUTICALS : Assigned Patent
2015 VERTEX PHARMACEUTICALS : Receives EU Approval for ORKAMBI® lumacaftor/ivacaftor,..
2015 VERTEX PHARMACEUTICALS : Receives Two EU Approvals for KALYDECO® ivacaftor for P..
2015 VERTEX PHARMACEUTICALS : to Present at the Piper Jaffray Healthcare Conference o..
2015 VERTEX PHARMACEUTICALS : EC grants marketing authorisation for Vertex's ORKAMBI ..
2015 VERTEX PHARMACEUTICALS : Appoints Michael J. Parini as Executive Vice President ..
2015 VERTEX PHARMACEUTICALS : Receives EU Approval for ORKAMBI® (lumacaftor/ivacaftor..
2015 VERTEX PHARMACEUTICALS : Receives Two EU Approvals for KALYDECO® (ivacaftor) for..
2015 VERTEX PHARMACEUTICALS : Assigned Patent
1  2  3  4  5  6  7Next
Advertisement
Financials ($)
Sales 2016 1 779 M
EBIT 2016 249 M
Net income 2016 33,6 M
Finance 2016 414 M
Yield 2016 -
P/E ratio 2016 932,37
P/E ratio 2017 42,26
EV / Sales 2016 12,8x
EV / Sales 2017 8,69x
Capitalization 23 224 M
More Financials
Chart VERTEX PHARMACEUTICALS INC
Duration : Period :
Vertex Pharmaceuticals Inc Technical Analysis Chart | VRTX | US92532F1003 | 4-Traders
Full-screen chart
Technical analysis trends VERTEX PHARMACEUT...
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus 
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 109 $
Spread / Average Target 16%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Jeffrey M. Leiden Chairman, President & Chief Executive Officer
Simon Bedson SVP & GM-International Commercial Operations
Ian F. Smith CFO, EVP & Principal Financial Officer
Jeffrey A. Chodakewitz Chief Medical Officer & Executive Vice President
David Matthew Altshuler Chief Scientific Officer & EVP-Global Research
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
VERTEX PHARMACEUTICALS..-25.38%23 224
AMGEN, INC.2.06%124 454
GILEAD SCIENCES, INC.-14.47%115 269
CELGENE CORPORATION-10.22%83 285
REGENERON PHARMACEUTIC..-27.91%41 121
ACTELION LTD21.78%19 820
More Results